Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01651780

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:37.353946+00:00

Published At

2017-02-27T00:00:00+00:00

Record Updated At

2017-04-07

Results Posted At

2017-02-27

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Severe Aortic Stenosis", "Transcatheter Aortic Valve Replacement", "Aortic Valve Replacement"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-04-07"

protocolSection.identificationModule.nctId

"NCT01651780"

protocolSection.identificationModule.officialTitle

"Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-02-27"

Study condition terms

• Severe Aortic Stenosis (protocolSection.conditionsModule.conditions)
• Transcatheter Aortic Valve Replacement (protocolSection.conditionsModule.conditions)
• Aortic Valve Replacement (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.